Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma

Cancer Letters

Volumn 269, Issue 1, 2008, Pages 85-92

  Ramankulov, Azizbek ^a,b   Lein, Michael ^a,c   Johannsen, Manfred ^a   Schrader, Mark ^a   Miller, Kurt ^a   Loening, Stefan A ^a   Jung, Klaus ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Republic Center of Urology   (Kyrgyzstan)

^c Berlin Institute for Urologic Research   (Germany)

Author keywords

Diagnostic marker; Metastasis; Prognosis; Renal cell carcinoma; Serum amyloid A

Indexed keywords

SERUM AMYLOID A; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TUMOR LOCALIZATION;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; SERUM AMYLOID A PROTEIN; TUMOR MARKERS, BIOLOGICAL;

EID: 49349114537     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.04.022     Document Type: Article

References (29)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., and Thun M.J. Cancer statistics. CA Cancer J. Clin. 58 (2008) 71-96
2. Russo P. Localized renal cell carcinoma. Curr. Treat. Options Oncol. 2 (2001) 447-455
3. Flanigan R.C., Campbell S.C., Clark J.I., and Picken M.M. Metastatic renal cell carcinoma. Curr. Treat. Options Oncol. 4 (2003) 385-390
4. Oda T., Miyao N., Takahashi A., Yanase M., Masumori N., Itoh N., Tamakawa M., and Tsukamoto T. Growth rates of primary and metastatic lesions of renal cell carcinoma. Int. J. Urol. 8 (2001) 473-477
5. Jung K., Lein M., Ringsdorf M., Roigas J., Schnorr D., Loening S.A., and Staack A. Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma. J. Urol. 176 (2006) 1326-1331
6. Tolson J., Bogumil R., Brunst E., Beck H., Elsner R., Humeny A., Kratzin H., Deeg M., Kuczyk M., Mueller G.A., Mueller C.A., and Flad T. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab. Invest. 84 (2004) 845-856
7. Chan D.C., Chen C.J., Chu H.C., Chang W.K., Yu J.C., Chen Y.J., Wen L.L., Huang S.C., Ku C.H., Liu Y.C., and Chen J.H. Evaluation of serum amyloid A as a biomarker for gastric cancer. Ann. Surg. Oncol. 14 (2007) 84-93
8. Engwegen J.Y., Mehra N., Haanen J.B., Bonfrer J.M., Schellens J.H., Voest E.E., and Beijnen J.H. Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations. Lab. Invest. 87 (2007) 161-172
9. Khan N., Cromer C.J., Campa M., and Patz Jr. E.F. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. Cancer 101 (2004) 379-384
10. Glojnaric I., Casl M.T., Simic D., and Lukac J. Serum amyloid A protein (SAA) in colorectal carcinoma. Clin. Chem. Lab. Med. 39 (2001) 129-133
11. Biran H., Friedman N., Neumann L., Pras M., and Shainkin-Kestenbaum R. Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis. J. Clin. Pathol. 39 (1986) 794-797
12. Moshkovskii S.A., Serebryakova M.V., Kuteykin-Teplyakov K.B., Tikhonova O.V., Goufman E.I., Zgoda V.G., Taranets I.N., Makarov O.V., and Archakov A.I. Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. Proteomics 5 (2005) 3790-3797
13. Yokoi K., Shih L.C., Kobayashi R., Koomen J., Hawke D., Li D., Hamilton S.R., Abbruzzese J.L., Coombes K.R., and Fidler I.J. Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancer. Int. J. Oncol. 27 (2005) 1361-1369
14. Nakayama T., Sonoda S., Urano T., Yamada T., and Okada M. Monitoring both serum amyloid protein A and C-reactive protein as inflammatory markers in infectious diseases. Clin. Chem. 39 (1993) 293-297
15. Kimura M., Tomita Y., Imai T., Saito T., Katagiri A., Ohara-Mikami Y., Matsudo T., and Takahashi K. Significance of serum amyloid A on the prognosis in patients with renal cell carcinoma. Cancer 92 (2001) 2072-2075
16. Sobin L.H., and Wittekind C. TNM classification of malignant tumours (1997), Wiley-Liss, New York
17. Rossi L., Martin B.M., Hortin G.L., White R.L., Foster M., Moharram R., Stroncek D., Wang E., Marincola F.M., and Panelli M.C. Inflammatory protein profile during systemic high dose interleukin-2 administration. Proteomics 6 (2006) 709-720
18. Solberg H.E. Approved recommendations (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determinations of reference limits. J. Clin. Chem. Clin. Biochem. 25 (1987) 645-656
19. Rosenthal C.J., and Sullivan L.M. Serum amyloid A to monitor cancer dissemination. Ann. Intern. Med. 91 (1979) 383-390
20. Ghezzi P., Bertini R., Bianchi M., Erroi A., Mengozzi M., Delgado R., and Giavazzi R. Serum amyloid A induction in tumor-bearing mice: evidence for a tumor-derived mediator. Int. J. Immunopathol. Pharmacol. 6 (1993) 169-186
21. Yamada T. Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin. Chem. Lab. Med. 37 (1999) 381-388
22. Malle E., and De Beer F.C. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur. J. Clin. Invest. 26 (1996) 427-435
23. Gutfeld O., Prus D., Ackerman Z., Dishon S., Linke R.P., Levin M., and Urieli-Shoval S. Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis. J. Histochem. Cytochem. 54 (2006) 63-73
24. Urieli-Shoval S., Cohen P., Eisenberg S., and Matzner Y. Widespread expression of serum amyloid A in histologically normal human tissues. Predominant localization to the epithelium. J. Histochem. Cytochem. 46 (1998) 1377-1384
25. Kovacevic A., Hammer A., Sundl M., Pfister B., Hrzenjak A., Ray A., Ray B.K., Sattler W., and Malle E. Expression of serum amyloid A transcripts in human trophoblast and fetal-derived trophoblast-like choriocarcinoma cells. FEBS Lett. 580 (2006) 161-167
26. Urieli-Shoval S., Linke R.P., and Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 7 (2000) 64-69
27. Mullan R.H., Bresnihan B., Golden-Mason L., Markham T., O'Hara R., FitzGerald O., Veale D.J., and Fearon U. Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway. Arthritis Rheum. 54 (2006) 105-114
28. O'Hara R., Murphy E.P., Whitehead A.S., FitzGerald O., and Bresnihan B. Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis. Arthritis Rheum. 50 (2004) 1788-1799
29. Henry N.L., and Hayes D.F. Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer. Oncologist 11 (2006) 541-552